期刊文献+

替托尼定与双氯芬酸治疗急性痉挛性肌痛的比较 被引量:2

Tizanidine vs diclofenac in treatment of acute painful muscle spasms
原文传递
导出
摘要 目的:临床观察和评估替托尼定治疗急性痉挛性肌痛的有效性和安全性。方法:急性痉挛性肌痛60例,男性39例,女性21例,年龄39±s9a。随机均分为3组,分别服用替托尼定1mg,tid,替托尼定1mg加双氯芬酸25mg,tid,双氯芬酸25mg,tid,共14d,观察在接触时、运动时、休息时及夜间在服药前后疼痛程度的变化;并记录不良反应。结果:3组服药d4的总有效率分别为81%,83%和65%。前2组的不良反应为轻微的嗜睡(10%)。结论:替托尼定较双氯芬酸更快、更有效地解除痉挛性肌痛(P<0.05),合适剂量为3mg/d。 AIM: To evaluate clinically the efficacy and tolerability of tizanidine in the treatment of acute painful muscle spasms. METHODS: Sixty patients (M 39, F 21, age 39±s 9 a) with acute painful muscle spasms were randomly and equally divided into 3 groups. Tizanidine (3 mg/d), tizanidine (3 mg/d) plus diclofenac (75 mg/d), and diclofenac (75 mg/d) were respectively given orally to each of the groups for 14 d. The severities of pain on palpation, during movement, at rest and at night were evaluated before and after administrations of the drugs, and the adverse reactions were recorded. RESULTS: The effective rates on d 4 after administration in 3 groups were 81%, 83% and 65%, respectively. The adverse reactions of tizanidine recorded were drowsinesses (10%) which were mild and transient. CONCLUSION: Tizanidine relieves the acute painful spasms more effectively and quicklier than diclofenac does (P<0.05). The suitable dosage for patients is 3 mg daily.
出处 《新药与临床》 CSCD 北大核心 1997年第5期281-283,共3页
关键词 替托尼定 双氯芬酸 痉挛性肌痛 治疗 tizanidine diclofenac muscle cramp
  • 相关文献

同被引文献11

  • 1劳志英.酮洛芬和双氯芬酸肌肉注射止痛作用的比较[J].新药与临床,1995,14(5):264-267. 被引量:3
  • 2Auchincloss S.The Painful Back:Practical Aspects of Management[J].Oxford:Medicine Publishing Foundation:1983.
  • 3Roland M.Back pain-An unresolved problem[J].Talkback,1983,4:4.
  • 4Kelsey JK,Cunningham L.Epidemiologic aspects of disability from rheumatic disease.In:Lawrence RC,Shulman LE,eds.Epidemiology of the Rheumatic Disease[M].Vol.42.New York:Gower;1984:302-311.
  • 5Ehsanullah RSB,Page MC,Tildesley G,Wood JR.Prevention of gastroduoenal damageinduced by no-steroidal anti-inflammatory drugs:Controllede trial of ranitidine[J].BMJ,1988,297:1017-1021.
  • 6Bijlsma Jwj.Treatment of endoscopy-negative NSAID-induced upper gastrointestinal sympotoms with cimetidine:An international multicentre collaborative study[J].AZiment Pharmacol Tker,1988,2:75-83.
  • 7Davies J,Johnstone SF.Br J Pharmacol 1983,82:409-21.
  • 8Watanabe K,Watanabe H,Maeda-Hagiwara M,Kanaoka R.Influence of a muscle relaxant,tizanidine,on gastric acid secretion and ulcers in the rat[J].Folia Pharmacol(Japan),1983,82:237-245.
  • 9McCarthy RJ,Kroni JS,Lubenow TR,et al.Effect of intrathecal tizanidine on antinociception and blood pressure in the rat[J].Pain,1990,40:333-338.
  • 10Rameyama T,Nabeshima T,Yamada S.Hypothermic and anti-inflammatory effects of tizanidine[J].Oyo Yakuri(Pharmacometrics),1986,30:867-871.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部